Office of Research & Development |
![]() ![]() |
Project Number: | I01CX001156-01A1 |
Title: | Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans? |
Principal Investigator: | George N. Ioannou |
Location: | Seattle, WA |
Congressional District Code: | 7 |
Research Service: | Clinical Science R&D |
Project Period: | July 2015 - December 2020 |
FY 2021 Funding Amount: | $0 |
Total Award Amount (all years): |
$585,230 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Hepatocellular carcinoma (HCC) is one of the most important clinical complications of chronic hepatitis B virus (HBV) infection. It has been suggested that HBV-infected patients should undergo screening for HCC with abdominal ultrasonography and possibly also serum alpha fetoprotein (AFP) testing. However, it is unclear if screening HBV-infected patients with these two tests reduces HCC-related mortality. Our Specific Aims are to: 1. Determine whether screening for HCC with abdominal ultrasono... |